Sanofi Says FDA Extends Review Target Date For Tolebrutinib
Refinitiv阅读少于1分钟
Sanofi SA 
SAN:
FDA EXTENDS REVIEW TARGET DATE FOR TOLEBRUTINIB
FDA DECISION DATE FOR TOLEBRUTINIB SET FOR DECEMBER 28, 2025
FDA CONSIDERS ADDITIONAL ANALYSES A MAJOR AMENDMENT TO NDA
登录或创建永久免费帐户以阅读此新闻